Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71205-098

5 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71205-098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Atorvastatin Calcium Tabs Form I A205300 1)

Chemical Structure (Atorvastatin Calcium Tabs Form I   A205300 1)
Chemical structure diagram of Atorvastatin Calcium showing its molecular arrangement including phenyl groups, hydroxyl groups, and calcium ions with associated water molecules (3 H2O).*
FDA Label Image

Figure 1 (Atorvastatin Calcium Tabs Form I A205300 2)

Figure 1 (Atorvastatin Calcium Tabs Form I   A205300 2)
A line graph showing cumulative incidence percentage over 3.5 years comparing Atorvastatin and placebo. The graph plots time in years on the x-axis and cumulative incidence (%) on the y-axis, with Atorvastatin represented by a solid line and placebo by a dashed line. Incidence is lower for Atorvastatin throughout the period.*
FDA Label Image

Figure 2 (Atorvastatin Calcium Tabs Form I A205300 3)

Figure 2 (Atorvastatin Calcium Tabs Form I   A205300 3)
A line graph comparing the cumulative hazard percentage over time to first primary endpoint through four years of follow-up for Atorvastatin versus placebo. The x-axis represents years, and the y-axis shows cumulative hazard percentage. The Atorvastatin group shows a lower cumulative hazard than the placebo group throughout the period.*
FDA Label Image

Figure 3 (Atorvastatin Calcium Tabs Form I A205300 4)

Figure 3 (Atorvastatin Calcium Tabs Form I   A205300 4)
A line graph showing the percentage of subjects experiencing a cardiovascular event over time (in years) for Atorvastatin 10 mg and 80 mg tablets. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The 80 mg group shows a lower event rate compared to the 10 mg group over approximately 5 years. Statistical results (HR 0.78, 95% CI 0.69 to 0.89, P = 0.0002) are included on the graph.*
FDA Label Image

71205-098-90 (Atorvastatin Calcium Tabs Form I A205300 8)

71205-098-90 (Atorvastatin Calcium Tabs Form I   A205300 8)
Label of Atorvastatin Calcium 80 mg tablets, film-coated, with a quantity of 90 tablets. The label shows the product is Rx only, manufactured by Teva Pharmaceutical Ind. Ltd. Israel, and relabeled by Proficient Rx LP. Storage instructions and tablet description (white to off-white, oval, debossed with 'TV' and '5057') are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.